Get 20% lifetime commission for referring investors to digrin.com
here.
Lixte Biotechnology Holdings, Inc. ( LIXT) - Stock Earnings
Stock symbol LIXT is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker LIXT was renamed to
NMAD
effective 2026-07-06.
LIXT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -1.4 million USD | — USD |
| 2023Q2 | -1.7 million USD | — USD |
| 2023Q3 | -1.0 million USD | — USD |
LIXT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -6.7 million USD | 0 USD |
| 2022 | -6.3 million USD | 0 USD |
| 2023 | -5.7 million USD | — USD |
LIXT
Price: $7.21
52 week price:
Earnings Per Share: -1.16 USD
P/E Ratio: -2.21
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 110300
Market Capitalization: 89.1 million